ASHA-624

N/A

Report date: 2023/12/14 18:18:26
NME

Base Information

Drug NameASHA-624
Drug Alias NameASHA624ASHA-624
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionNAD(+) hydrolase SARM1 inhibitors
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsGlaucomaPeripheral Nervous System DiseasesSpinal Cord Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsha Theraputics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAsha Theraputics LLC
Inactive CompaniesN/A
Active IndicationsGlaucomaPeripheral Nervous System DiseasesSpinal Cord Injuries +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A